Camella Marisse Lau
Family · Henderson, NVNPI 1326811944
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 28.5% of the total. 2025 is the largest year on record at $2,282, 2.4 times the $970 reported in 2023. Among family clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $101.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$728
- Gilead$561
- Novo Nordisk$358
- Idorsia Pharmaceuticals US Inc$248
- Dexcom, Inc.$156
- plus $2K from 16 others
What the payments were for
- Food & beverage$5,373100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 12 | $1,532 |
| AstraZeneca | 7 | $728 |
| Gilead | 12 | $561 |
| Novo Nordisk | 3 | $358 |
| Idorsia Pharmaceuticals US Inc | 2 | $248 |
| Dexcom, Inc. | 1 | $156 |
| Daiichi Sankyo Inc. | 1 | $135 |
| Phathom Pharmaceuticals, Inc. | 1 | $133 |
| Grifols USA, LLC | 1 | $125 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $124 |
| Amylyx Pharmaceuticals, Inc. | 1 | $122 |
| Kyowa Kirin, Inc. | 1 | $122 |
| Xeris Pharmaceuticals, Inc. | 1 | $122 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $120 |
| Argenx US, Inc. | 1 | $120 |
| Fresenius Kabi USA, LLC | 1 | $116 |
| Jazz Pharmaceuticals Inc. | 1 | $111 |
| Otsuka America Pharmaceutical, Inc. | 1 | $108 |
| Johnson & Johnson | 1 | $108 |
| Braeburn Inc. | 1 | $93 |
| Recordati_rare_diseases_inc. | 1 | $88 |
| Minerva Surgical, Inc | 1 | $44 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QULIPTA$912
- UBRELVY$763
- VRAYLAR$398
- QUVIVIQ$248
- FASENRA$245
- Wegovy$239
- FARXIGA$222
- DEXCOM G6 TRANSMITTER$156
- INJECTAFER$135
- VOQUEZNA$133
- Prolastin-C Liquid$125
- EPKINLY$125
- CAPLYTA$124
- Descovy$124
- RELYVRIO$122
- GVOKE HYPOPEN$122
- Vemlidy$122
- LUMRYZ$120
- WAINUA$120
- VYVGART HYTRULO$120
How this compares
$5,373 in reported general payments places this provider in the 90th percentile of 1,501 family providers in Nevada.
Other family in Henderson
- Kristy SolisHenderson$23K
- Joseph LauHenderson$18K
- Judith YuHenderson$14K
- Daniel Sam AciertoHenderson$11K
- Reiko TapiaHenderson$10K
- Francis TorresHenderson$8K
- Hollie TylerLas Vegas$118K
- John PhoenixLas Vegas$107K
- Jon FaillaLas Vegas$74K
- Alex LapasaranLas Vegas$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.